China Botulinum Neurotoxins Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Botulinum Neurotoxins industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Galderma

    • Anterios

    • PharmaVital

    • Valeant Pharmaceuticals

    • Merz Pharma

    • Alphaeon

    • CNBG

    • Revance Therapeutics

    • Hugel

    • Ipsen

    • Johnson & Johnson

    • GSK

    • EpiVax

    • Escape Therapeutics

    • Transdermal

    • CROMA

    • Nestle

    • Medy-Tox

    • Mentor

    • OBI Pharma

    • Eisai

    • Malvern Cosmeceutics

    • Chong Kun Dang

    By Type:

    • Botulinum Neurotoxins A (BoNT/A)

    • Botulinum Neurotoxins E (BoNT/E)

    • Botulinum Neurotoxins D (BoNT/D)

    • Botulinum Neurotoxins C (BoNT/C)

    • Botulinum Neurotoxins G (BoNT/G)

    • Botulinum Neurotoxins B (BoNT/B)

    • Botulinum Neurotoxins F (BoNT/F)

    By Application:

    • Cosmetics

    • Medical Uses

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Botulinum Neurotoxins Market Overview 2018-2029

    • 1.1 China Botulinum Neurotoxins Industry Development Overview

    • 1.2 China Botulinum Neurotoxins Industry Development History

    • 1.3 China Botulinum Neurotoxins Industry Market Size (2018-2029)

    • 1.4 China Botulinum Neurotoxins Market Analysis by Type from Production Side

      • 1.4.1 China Botulinum Neurotoxins Production Volume, Production Value and Growth Rate of Botulinum Neurotoxins A (BoNT/A) (2018-2029)

      • 1.4.2 China Botulinum Neurotoxins Production Volume, Production Value and Growth Rate of Botulinum Neurotoxins E (BoNT/E) (2018-2029)

      • 1.4.3 China Botulinum Neurotoxins Production Volume, Production Value and Growth Rate of Botulinum Neurotoxins D (BoNT/D) (2018-2029)

      • 1.4.4 China Botulinum Neurotoxins Production Volume, Production Value and Growth Rate of Botulinum Neurotoxins C (BoNT/C) (2018-2029)

      • 1.4.5 China Botulinum Neurotoxins Production Volume, Production Value and Growth Rate of Botulinum Neurotoxins G (BoNT/G) (2018-2029)

      • 1.4.6 China Botulinum Neurotoxins Production Volume, Production Value and Growth Rate of Botulinum Neurotoxins B (BoNT/B) (2018-2029)

      • 1.4.7 China Botulinum Neurotoxins Production Volume, Production Value and Growth Rate of Botulinum Neurotoxins F (BoNT/F) (2018-2029)

    • 1.5 China Botulinum Neurotoxins Market Analysis by Application from Consumption End

      • 1.5.1 China Botulinum Neurotoxins Sales Volume, Sales Value and Growth Rate of Cosmetics (2018-2029)

      • 1.5.2 China Botulinum Neurotoxins Sales Volume, Sales Value and Growth Rate of Medical Uses (2018-2029)

    • 1.6 China Botulinum Neurotoxins Market Analysis by Region

      • 1.6.1 North China Botulinum Neurotoxins Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Botulinum Neurotoxins Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Botulinum Neurotoxins Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Botulinum Neurotoxins Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Botulinum Neurotoxins Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Botulinum Neurotoxins Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Botulinum Neurotoxins Market Size and Growth Rate from 2018-2029

    Chapter 2 China Botulinum Neurotoxins Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Botulinum Neurotoxins Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Botulinum Neurotoxins Market Status and Competition Analysis in 2023

      • 2.2.3 China Botulinum Neurotoxins Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Botulinum Neurotoxins Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Botulinum Neurotoxins Industry Development

    Chapter 3 Botulinum NeurotoxinsIndustry Chain Analysis

    • 3.1 Botulinum Neurotoxins Industry Chain

    • 3.2 Botulinum Neurotoxins Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Botulinum Neurotoxins Market

    • 3.3 Botulinum Neurotoxins Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Botulinum Neurotoxins Market

    Chapter 4 China Botulinum Neurotoxins Market, by Type

    • 4.1 China Botulinum Neurotoxins Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Botulinum Neurotoxins Total Production Volume and Growth Rate from Production Side

    • 4.5 China Botulinum Neurotoxins Production Volume and Growth Rate, by Type

      • 4.5.1 China Botulinum Neurotoxins Production Volume and Growth Rate of Botulinum Neurotoxins A (BoNT/A)

      • 4.5.2 China Botulinum Neurotoxins Production Volume and Growth Rate of Botulinum Neurotoxins E (BoNT/E)

      • 4.5.3 China Botulinum Neurotoxins Production Volume and Growth Rate of Botulinum Neurotoxins D (BoNT/D)

      • 4.5.4 China Botulinum Neurotoxins Production Volume and Growth Rate of Botulinum Neurotoxins C (BoNT/C)

      • 4.5.5 China Botulinum Neurotoxins Production Volume and Growth Rate of Botulinum Neurotoxins G (BoNT/G)

      • 4.5.6 China Botulinum Neurotoxins Production Volume and Growth Rate of Botulinum Neurotoxins B (BoNT/B)

      • 4.5.7 China Botulinum Neurotoxins Production Volume and Growth Rate of Botulinum Neurotoxins F (BoNT/F)

    Chapter 5 China Botulinum Neurotoxins Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Botulinum Neurotoxins Total Market Size and Growth Rate from Consumption End

    • 5.5 China Botulinum Neurotoxins Market Size and Growth Rate, by Application

      • 5.5.1 China Botulinum Neurotoxins Market Size and Growth Rate of Cosmetics

      • 5.5.2 China Botulinum Neurotoxins Market Size and Growth Rate of Medical Uses

    Chapter 6 China Botulinum Neurotoxins Market, by Region

    • 6.1 China Botulinum Neurotoxins Production Volume and Production Value, by Region

    • 6.2 China Botulinum Neurotoxins Sales Volume and Sales Value, by Region

    Chapter 7 North China Botulinum Neurotoxins Market Analysis

    • 7.1 North China Botulinum Neurotoxins Market, by Type

    • 7.2 North China Botulinum Neurotoxins Market, by Application

    Chapter 8 Central China Botulinum Neurotoxins Market Analysis

    • 8.1 Central China Botulinum Neurotoxins Market, by Type

    • 8.2 Central China Botulinum Neurotoxins Market, by Application

    Chapter 9 South China Botulinum Neurotoxins Market Analysis

    • 9.1 South China Botulinum Neurotoxins Market, by Type

    • 9.2 South China Botulinum Neurotoxins Market, by Application

    Chapter 10 East China Botulinum Neurotoxins Market Analysis

    • 10.1 East China Botulinum Neurotoxins Market, by Type

    • 10.2 East China Botulinum Neurotoxins Market, by Application

    Chapter 11 Northeast China Botulinum Neurotoxins Market Analysis

    • 11.1 Northeast China Botulinum Neurotoxins Market, by Type

    • 11.2 Northeast China Botulinum Neurotoxins Market, by Application

    Chapter 12 Southwest China Botulinum Neurotoxins Market Analysis

    • 12.1 Southwest China Botulinum Neurotoxins Market, by Type

    • 12.2 Southwest China Botulinum Neurotoxins Market, by Application

    Chapter 13 Northwest China Botulinum Neurotoxins Market Analysis

    • 13.1 Northwest China Botulinum Neurotoxins Market, by Type

    • 13.2 Northwest China Botulinum Neurotoxins Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Galderma

        • 14.1.1 Galderma Company Profile

        • 14.1.2 Galderma Botulinum Neurotoxins Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Anterios

        • 14.2.1 Anterios Company Profile

        • 14.2.2 Anterios Botulinum Neurotoxins Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 PharmaVital

        • 14.3.1 PharmaVital Company Profile

        • 14.3.2 PharmaVital Botulinum Neurotoxins Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Valeant Pharmaceuticals

        • 14.4.1 Valeant Pharmaceuticals Company Profile

        • 14.4.2 Valeant Pharmaceuticals Botulinum Neurotoxins Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Merz Pharma

        • 14.5.1 Merz Pharma Company Profile

        • 14.5.2 Merz Pharma Botulinum Neurotoxins Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Alphaeon

        • 14.6.1 Alphaeon Company Profile

        • 14.6.2 Alphaeon Botulinum Neurotoxins Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 CNBG

        • 14.7.1 CNBG Company Profile

        • 14.7.2 CNBG Botulinum Neurotoxins Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Revance Therapeutics

        • 14.8.1 Revance Therapeutics Company Profile

        • 14.8.2 Revance Therapeutics Botulinum Neurotoxins Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Hugel

        • 14.9.1 Hugel Company Profile

        • 14.9.2 Hugel Botulinum Neurotoxins Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Ipsen

        • 14.10.1 Ipsen Company Profile

        • 14.10.2 Ipsen Botulinum Neurotoxins Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Johnson & Johnson

        • 14.11.1 Johnson & Johnson Company Profile

        • 14.11.2 Johnson & Johnson Botulinum Neurotoxins Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 GSK

        • 14.12.1 GSK Company Profile

        • 14.12.2 GSK Botulinum Neurotoxins Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 EpiVax

        • 14.13.1 EpiVax Company Profile

        • 14.13.2 EpiVax Botulinum Neurotoxins Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Escape Therapeutics

        • 14.14.1 Escape Therapeutics Company Profile

        • 14.14.2 Escape Therapeutics Botulinum Neurotoxins Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Transdermal

        • 14.15.1 Transdermal Company Profile

        • 14.15.2 Transdermal Botulinum Neurotoxins Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 CROMA

        • 14.16.1 CROMA Company Profile

        • 14.16.2 CROMA Botulinum Neurotoxins Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Nestle

        • 14.17.1 Nestle Company Profile

        • 14.17.2 Nestle Botulinum Neurotoxins Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Medy-Tox

        • 14.18.1 Medy-Tox Company Profile

        • 14.18.2 Medy-Tox Botulinum Neurotoxins Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Mentor

        • 14.19.1 Mentor Company Profile

        • 14.19.2 Mentor Botulinum Neurotoxins Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 OBI Pharma

        • 14.20.1 OBI Pharma Company Profile

        • 14.20.2 OBI Pharma Botulinum Neurotoxins Market Performance

        • 14.20.3 Product&Service Introduction

      • 14.21 Eisai

        • 14.21.1 Eisai Company Profile

        • 14.21.2 Eisai Botulinum Neurotoxins Market Performance

        • 14.21.3 Product&Service Introduction

      • 14.22 Malvern Cosmeceutics

        • 14.22.1 Malvern Cosmeceutics Company Profile

        • 14.22.2 Malvern Cosmeceutics Botulinum Neurotoxins Market Performance

        • 14.22.3 Product&Service Introduction

      • 14.23 Chong Kun Dang

        • 14.23.1 Chong Kun Dang Company Profile

        • 14.23.2 Chong Kun Dang Botulinum Neurotoxins Market Performance

        • 14.23.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Botulinum Neurotoxins Industry Research Conclusions

    • 15.2 Botulinum Neurotoxins Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Botulinum Neurotoxins Industry Market Size (2018-2029)

    • Figure China Botulinum Neurotoxins Production Volume, Production Value and Growth Rate of Botulinum Neurotoxins A (BoNT/A) (2018-2029)

    • Figure China Botulinum Neurotoxins Production Volume, Production Value and Growth Rate of Botulinum Neurotoxins E (BoNT/E) (2018-2029)

    • Figure China Botulinum Neurotoxins Production Volume, Production Value and Growth Rate of Botulinum Neurotoxins D (BoNT/D) (2018-2029)

    • Figure China Botulinum Neurotoxins Production Volume, Production Value and Growth Rate of Botulinum Neurotoxins C (BoNT/C) (2018-2029)

    • Figure China Botulinum Neurotoxins Production Volume, Production Value and Growth Rate of Botulinum Neurotoxins G (BoNT/G) (2018-2029)

    • Figure China Botulinum Neurotoxins Production Volume, Production Value and Growth Rate of Botulinum Neurotoxins B (BoNT/B) (2018-2029)

    • Figure China Botulinum Neurotoxins Production Volume, Production Value and Growth Rate of Botulinum Neurotoxins F (BoNT/F) (2018-2029)

    • Figure China Botulinum Neurotoxins Sales Volume, Sales Value and Growth Rate of Cosmetics (2018-2029)

    • Figure China Botulinum Neurotoxins Sales Volume, Sales Value and Growth Rate of Medical Uses (2018-2029)

    • Figure North China Botulinum Neurotoxins Market Size and Growth Rate from 2018-2029

    • Figure Central China Botulinum Neurotoxins Market Size and Growth Rate from 2018-2029

    • Figure South China Botulinum Neurotoxins Market Size and Growth Rate from 2018-2029

    • Figure East China Botulinum Neurotoxins Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Botulinum Neurotoxins Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Botulinum Neurotoxins Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Botulinum Neurotoxins Market Size and Growth Rate from 2018-2029

    • Figure Botulinum Neurotoxins Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Botulinum Neurotoxins Market Share by Type in 2018

    • Figure China Botulinum Neurotoxins Market Share by Type in 2023

    • Figure China Botulinum Neurotoxins Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Botulinum Neurotoxins Production Volume and Growth Rate of Botulinum Neurotoxins A (BoNT/A) (2018-2023)

    • Figure China Botulinum Neurotoxins Production Volume and Growth Rate of Botulinum Neurotoxins E (BoNT/E) (2018-2023)

    • Figure China Botulinum Neurotoxins Production Volume and Growth Rate of Botulinum Neurotoxins D (BoNT/D) (2018-2023)

    • Figure China Botulinum Neurotoxins Production Volume and Growth Rate of Botulinum Neurotoxins C (BoNT/C) (2018-2023)

    • Figure China Botulinum Neurotoxins Production Volume and Growth Rate of Botulinum Neurotoxins G (BoNT/G) (2018-2023)

    • Figure China Botulinum Neurotoxins Production Volume and Growth Rate of Botulinum Neurotoxins B (BoNT/B) (2018-2023)

    • Figure China Botulinum Neurotoxins Production Volume and Growth Rate of Botulinum Neurotoxins F (BoNT/F) (2018-2023)

    • Figure China Botulinum Neurotoxins Market Share by Application in 2018

    • Figure China Botulinum Neurotoxins Market Share by Application in 2023

    • Figure China Botulinum Neurotoxins Total Market Size and Growth Rate from Consumption End

    • Figure China Botulinum Neurotoxins Market Size and Growth Rate of Cosmetics (2018-2023)

    • Figure China Botulinum Neurotoxins Market Size and Growth Rate of Medical Uses (2018-2023)

    • Table China Botulinum Neurotoxins Production Volume by Region (2018-2023)

    • Table China Botulinum Neurotoxins Production Volume Share by Region (2018-2023)

    • Figure China Botulinum Neurotoxins Production Volume Share by Region (2018-2023)

    • Table China Botulinum Neurotoxins Production Value by Region (2018-2023)

    • Table China Botulinum Neurotoxins Production Value Share by Region (2018-2023)

    • Figure China Botulinum Neurotoxins Production Value Share by Region (2018-2023)

    • Table China Botulinum Neurotoxins Sales Volume by Region (2018-2023)

    • Table China Botulinum Neurotoxins Sales Volume Share by Region (2018-2023)

    • Figure China Botulinum Neurotoxins Sales Volume Share by Region (2018-2023)

    • Table China Botulinum Neurotoxins Sales Value by Region (2018-2023)

    • Table China Botulinum Neurotoxins Sales Value Share by Region (2018-2023)

    • Figure China Botulinum Neurotoxins Sales Value Share by Region (2018-2023)

    • Table North China Botulinum Neurotoxins Production Volume by Type (2018-2023)

    • Table North China Botulinum Neurotoxins Production Volume Share by Type (2018-2023)

    • Figure North China Botulinum Neurotoxins Production Volume Share by Type (2018-2023)

    • Table North China Botulinum Neurotoxins Sales Volume by Application (2018-2023)

    • Table North China Botulinum Neurotoxins Sales Volume Share by Application (2018-2023)

    • Figure North China Botulinum Neurotoxins Sales Volume Share by Application (2018-2023)

    • Table Central China Botulinum Neurotoxins Production Volume by Type (2018-2023)

    • Table Central China Botulinum Neurotoxins Production Volume Share by Type (2018-2023)

    • Figure Central China Botulinum Neurotoxins Production Volume Share by Type (2018-2023)

    • Table Central China Botulinum Neurotoxins Sales Volume by Application (2018-2023)

    • Table Central China Botulinum Neurotoxins Sales Volume Share by Application (2018-2023)

    • Figure Central China Botulinum Neurotoxins Sales Volume Share by Application (2018-2023)

    • Table South China Botulinum Neurotoxins Production Volume by Type (2018-2023)

    • Table South China Botulinum Neurotoxins Production Volume Share by Type (2018-2023)

    • Figure South China Botulinum Neurotoxins Production Volume Share by Type (2018-2023)

    • Table South China Botulinum Neurotoxins Sales Volume by Application (2018-2023)

    • Table South China Botulinum Neurotoxins Sales Volume Share by Application (2018-2023)

    • Figure South China Botulinum Neurotoxins Sales Volume Share by Application (2018-2023)

    • Table East China Botulinum Neurotoxins Production Volume by Type (2018-2023)

    • Table East China Botulinum Neurotoxins Production Volume Share by Type (2018-2023)

    • Figure East China Botulinum Neurotoxins Production Volume Share by Type (2018-2023)

    • Table East China Botulinum Neurotoxins Sales Volume by Application (2018-2023)

    • Table East China Botulinum Neurotoxins Sales Volume Share by Application (2018-2023)

    • Figure East China Botulinum Neurotoxins Sales Volume Share by Application (2018-2023)

    • Table Northeast China Botulinum Neurotoxins Production Volume by Type (2018-2023)

    • Table Northeast China Botulinum Neurotoxins Production Volume Share by Type (2018-2023)

    • Figure Northeast China Botulinum Neurotoxins Production Volume Share by Type (2018-2023)

    • Table Northeast China Botulinum Neurotoxins Sales Volume by Application (2018-2023)

    • Table Northeast China Botulinum Neurotoxins Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Botulinum Neurotoxins Sales Volume Share by Application (2018-2023)

    • Table Southwest China Botulinum Neurotoxins Production Volume by Type (2018-2023)

    • Table Southwest China Botulinum Neurotoxins Production Volume Share by Type (2018-2023)

    • Figure Southwest China Botulinum Neurotoxins Production Volume Share by Type (2018-2023)

    • Table Southwest China Botulinum Neurotoxins Sales Volume by Application (2018-2023)

    • Table Southwest China Botulinum Neurotoxins Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Botulinum Neurotoxins Sales Volume Share by Application (2018-2023)

    • Table Northwest China Botulinum Neurotoxins Production Volume by Type (2018-2023)

    • Table Northwest China Botulinum Neurotoxins Production Volume Share by Type (2018-2023)

    • Figure Northwest China Botulinum Neurotoxins Production Volume Share by Type (2018-2023)

    • Table Northwest China Botulinum Neurotoxins Sales Volume by Application (2018-2023)

    • Table Northwest China Botulinum Neurotoxins Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Botulinum Neurotoxins Sales Volume Share by Application (2018-2023)

    • Table Galderma Company Profile

    • Table Galderma Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Anterios Company Profile

    • Table Anterios Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table PharmaVital Company Profile

    • Table PharmaVital Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Valeant Pharmaceuticals Company Profile

    • Table Valeant Pharmaceuticals Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Merz Pharma Company Profile

    • Table Merz Pharma Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Alphaeon Company Profile

    • Table Alphaeon Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table CNBG Company Profile

    • Table CNBG Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Revance Therapeutics Company Profile

    • Table Revance Therapeutics Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Hugel Company Profile

    • Table Hugel Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Ipsen Company Profile

    • Table Ipsen Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table GSK Company Profile

    • Table GSK Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table EpiVax Company Profile

    • Table EpiVax Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Escape Therapeutics Company Profile

    • Table Escape Therapeutics Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Transdermal Company Profile

    • Table Transdermal Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table CROMA Company Profile

    • Table CROMA Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Nestle Company Profile

    • Table Nestle Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Medy-Tox Company Profile

    • Table Medy-Tox Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Mentor Company Profile

    • Table Mentor Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table OBI Pharma Company Profile

    • Table OBI Pharma Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Eisai Company Profile

    • Table Eisai Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Malvern Cosmeceutics Company Profile

    • Table Malvern Cosmeceutics Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)

    • Table Chong Kun Dang Company Profile

    • Table Chong Kun Dang Botulinum Neurotoxins Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.